Sirion Holdings, Inc.

Roche Holding AG , Genentech, Inc. and their affiliated companies were the busiest deal makers in the biopharmaceutical sector for the second consecutive year in 2021, with 23 deals across all cate

AstraZeneca: 2019 Net Price Decreases AstraZeneca PLC 's 2019 net prices on average across the portfolio will decrease versus 2018, Senior VP-Market Access Rick Suarez said in an interview at J.P. Mo

AstraZeneca On 2019 Net Prices AstraZeneca PLC 's 2019 net prices on average across the portfolio will decrease versus 2018, although the company will take price increases on some products, Senior VP

Bristol-Myers Squibb Co. 's purchase of Amira Pharmaceuticals Inc. for $325 million up front and another $150 million in downstream milestones shows that prior licensing deals and multiple progra